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Abstract--Aim. To derive closed-loop insulin infusion algorithms for the metabolic control of hospitalized, 
non-insulin-producing subjects. 
Methodology. Biological systems are frequently complex and non-linear. One hindrance to the 
application of methods of optimal control theory has been that when they are applied to non-linear 
systems it is often difficult, if not impossible, to derive a practical closed-loop control algorithm. Because 
of this, optimal control theory has not produced the same successes in biological areas as in other 
disciplines. The method of "discrete segments" attempts to avoid the open-loop results of other 
approaches by considering the control variable to consist of a number of small, discrete sections. With 
an additional assumption concerning the duration of the "effect" of one of these small sections, the 
optimization problem presented in this study is reformulated sothat individual sections of the control may 
be found in terms of quantities known at earlier times. The full control strategy isderived by setting partial 
derivatives of the cost function (with respect to the control segments) equal to zero. The clinical situation 
of a diabetic patient (normal, insulin resistant or glucose resistan0 presenting with mild, post-operative 
hyperglycaemia (PG = 10 mmol/1) is modelled using the "minimal" model of Bergman et al., as modified 
for the diabetic state by Furler et al. A cost criterion was postulated and an algorithm for choosing the 
appropriate infusion rate regime was derived using the "discrete segments" approach. 
Conclusions. The method of "discrete segments" can be an effective alternative to the usual methods 
of optimal control theory. The insulin infusion rate algorithm derived in this study has a dosed-loop form 
and procedures good metabolic ontrol in the theoretical framework. 
To derive closed-loop insulin infusion 
non-insulin-producing subjects. 
1. AIM 
algorithms for the metabolic ontrol of hospitalized, 
2. METHODOLOGY 
Both mathematical modelling and optimal control theory have enjoyed great success in the areas 
of physics, engineering and operations research. Biological systems, however, tend to be less readily 
analysed and measured, and thus less amenable to control. Swan [1] highlights ome of the scope 
available for the application of optimal control theory to insulin therapy for the diabetic. One 
drawback with these methods has been that when they are applied to non-linear systems it is often 
difficult, if not impossible, to derive a practical closed-loop control algorithm. In general, 
closed-loop control aws are preferred since they are simpler to implement and less susceptible to 
errors in the modelling process, whereas open-loop laws may in time be setting controls that bear 
no relationship to the actual physical state. Because of this, optimal control theory has not 
produced the same successes in biological areas as in other disciplines. 
The method of "discrete segments" attempts to avoid the open-loop results of other approaches 
by considering the control variable to consist of a number of small, discrete sections. With an 
additional assumption concerning the duration of the "effect" of one of these small sections, the 
optimization problem presented in this study is reformulated so that individual sections of the 
control may be found in terms of quantities known at earlier times. The full control strategy is 
derived by setting partial derivatives of the cost function (with respect o the control segments) 
equal to zero. 
Bergman et al. [2-5] describe a non-linear model of glucose/insulin kinetics and report hat the 
model accounts for subjects' plasma glucose levels in a variety of situations. 
Furler et al. [6] have adapted this model to describe a hospitalized iabetic receiving insulin via 
a computer-assisted insulin infusion system. They also consider the effects of insulin antibodies, 
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Table I. Parameter sets used with Bergman's "minimal" model 
Parameter 
Parameter sets 
1 2 3 
Insulin Glucose 
Normal resistant resistant 
Pl (min- i) 0.028 0.028 0.0 
P2 (min- s) 0.025 0.025 0.025 
p3 (rain-2 mU -I I) 0.000013 0.000005 0.000013 
Table 2. Parameters applicable to all situations considered in this 
study 
Gs (retool/I) 4.5 
t, (mU/D ] 5.0 
G O (retool/1) 10.0 
X 0 (rain - t) 0.0 
I o (mU/l) 0.0 
n (rain- i) 0.09 
V, (I) 12.0 
v~ O) 15.0 
Gin r (mmol/I/min) 0.0 or 0.026 (a conservative 
value corresponding to an 
infusion of 100 g/24 h) 
Umi. (mU/1/min) 3.47 (2.5 U/Vjh) 
u~ (mU/I/min) 0.69 (0.5 U/VI/h) 
T (rain) 2160.0 (36 h) 
X~ (min-1) Gi.r/G s 
P2Gi.f P2X# /~ (mU/t) 
P3 GB /)3 
~(P2 Ginf + IB) U= (mU/I/min) = n(/~ + IG) 
P3 Gs 
which tend to keep glucose levels closer to basal values. The antibody effect has not been 
incorporated into this study as we wish to include "worst-case" behaviour (while still giving a good 
fit experimentally) and also keep the number of model parameters to a minimum. 
Three parameter sets are used to span the possible ranges of behaviour (normal, insulin resistant 
and glucose resistant, as in the Furler et al. study [6]). These are shown in Table 1. The presence 
or absence of a glucose infusion is also considered since this may model glucose input after a meal 
or a post-operative glucose drip. Parameters applicable to all situations in this study are given in 
Table 2. 
In the present study, the clinical situation of a diabetic patient (normal, insulin resistant 
or glucose resistant) presenting with mild post-operative hyperglycaemia (PG = 10mmol/l) is 
modelled. 
A cost criterion was postulated and an algorithm for choosing the appropriate infusion rate 
regimen was derived using the "discrete segments" approach. (See Ref. [7] for another application 
of this method.) 
The cost criterion to be minimized is 
J = f [o(t) - O.] 2 dt. 
This was postulated on the basis of the requirement to minimize diffcrmaces between actual plasma 
glucose (G) levels and the desired basal evel (GB). The difference between the actual value and the 
desired value is squared so that levels above and below that desired are both treated as adding to 
the "cost". The values at different imes are then added together (integrated) to obtain the final 
total cost of using a particular control sequence (insulin infusion) over a period of time (T). Athans 
and Falb [8] and Bryson and Ho [9] discuss performance indices in greater detail. 
The model (with the notation slightly modified) is as follows: 
(~(t) = -[p~ + X(t)]G(t)  +P4 + Ginf, G(O) = Go, (1) 
J((t) = --Pz X(t  ) + P3 I(t),  X(O) = Xo, (2) 
](t) = u(t) - n[I(t) + IB] l(O) = Io, (3) 
with Umi, ~< u(t) <<, Um~x; and where 
G--the plasma glucose level (mmol/l), 
X--models insulin's effect to facilitate plasma glucose uptake (min -1), 
/ - -the insulin level above basal (mUff), 
/B - - the  basal insulin level (mU/ l ) ,  
GB--the basal glucose level (retool/l), 
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and 
P~, P2, P3, n--subject-dependent model parameters (rain-~ ), 
P4 = Pl GB (mmol/1/min), 
Ginf--the glucose infusion rate (corresponding to the Fuder et al. Fo/Vo 
term [61), 
u--the insulin infusion rate (corresponding to the Furler et al. F~/VI 
term [6]), 
Umi., u.~ax--the lower and upper insulin infusion rate bounds, as in Ref. [6] and 
chosen mainly for reasons of safety 
Go, Xo, I0--are the initial values of G, X and L respectively. They also are as in 
Ref. [6]. 
Note. Strictly speaking the insulin infusion rate, u, has units of mU/l/min but for clarity the 
diagrams and discussion in this study treat u simply as an infusion rate with units of U/h. The 
conversion factor is 3V~/50. The insulin volume is VI = 121 in this study. Similarly the glucose 
infusion rate, Ginf, has units of mmol/l/min but is spoken of in terms of g/24h. The conversion factor 
is 125VG/12. The glucose volume is V c = 151 in this study. 
The model is basically "compartmental" in nature, containing lucose (G), insulin "effect" (X) 
and insulin (I) pools. Positive terms on the r.h.s, of equations (1)-(3) tend to increase the amount 
of substance in the respective compartment (denoted by the l.h.s, of each equation) while 
negative terms represent a flow out of the compartment. Figure 1 gives a schematic outline of the 
model. 
3. ANALYSIS 
The method of "discrete segments" involves discretizing the optimization problem. The control 
variable, u, is considered to be made up of a large number of constant sections (u,). We then set 
about finding the set of u,s that minimize the cost function. Different cases of glucose infusions 
and parameter sets are explored. 
Beginning with the system equations (1)-(3), we can integrate quations (2) and (3) analytically 
if u =u,  is constant over some short time interval (Tk, T,+1), where T,+I -  Tk=~t. Also, if 
Insulin 
independent 
glucose 
source P4 
J External glucose source Ginf J 
Insu Li n 
"effect" 
I Insulin I 
J source u I degradation 
I, "1 Tissue / Liver ] 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
~ _~ InsuLin "effect" X degradation 
Fig. 1. The "minimal" model of Bergman et al. (including insulin compartments applicable to the diabetic 
state). Horizontal and vertical lines represent "flows". The diagonal line represents a "signal" and affects 
the corresponding flow rates. 
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equation (1) is replaced by its discrete Euler approximation, the problem becomes: find the set {uk } 
that minimizes the discrete form of the cost function J, subject o the discrete recursion equations 
G,+, = [--(Pl + X,)G, +/74 + G,.f]ft + G,. (4) 
X,+ i = ukD] + X, D2 + ItD3 + D 4 (5) 
and 
Ik + l = UkE I + Ikf~ 2 -[- g 3 (6 )  
where Gk, X, and Ik are the values (readings or model predictions) of G, X and I at the beginning 
of stage k (time T,). u, is the constant value of the infusion rate over this short time interval. 
The Ds and Es are constants (dependent upon 6t), given by 
D I = P3n [[1 -- exp(--p2 6t ) ]p2  - [exp(--P2 6t)(n ---p2eXp(-- n tS t ) ]q )  _1' 
D2 = exp( -p2 dit), 
[exp(--p2 ~t) - exp( - n6t)] 
D3 = P3 
(n - p2) 
D4 = _p3in[! l  -- exp( - -p26t ) ]  [exp(--p26t ) - exp( -  n6t)] 1 
p2 J' 
[1 - exp(-n6t)]  
E I = 
n 
and 
E2 = exp( -- n6t) 
E3 = --IB[1 -- exp(--m~t)]. 
The cost criterion to be minimized becomes 
N 
] ~ 8t ~ (G, - GB) 2. 
k=0 
Before taking derivatives of J, with respect o uk, it is helpful to see that uk has a "cascading" 
effect on all stages after stage k. This is illustrated in Fig. 2. As the problem stands, any variation 
in u, affects all subsequent stages. To solve the set of equations 
8J 
- -=0 (k =0 to N) 
diUk 
requires an intial approximate set of short infusion rates, {uk}, which would be varied by standard 
techniques until the optimal set was found. This, unfortunately, necessitates an open-loop solution. 
In an attempt o avoid this, we consider that Uk first affects Gk + 2 (see Fig. 2) and then only s stages 
after to Gk + s + 2. This transient effect seems reasonable since each uk is set for only a short time and 
would become less and less important amongst he effects of later uk +is. Figure 3 illustrates these 
concepts. 
U k 
/ \  
Tk+ I Xk+1 
/ x / \  
Zk.2 Xk+2 Gk+2 / \  / 'X  / ' x  
rk+3 Xk+3 Gk+3 
Zk+4 Xk+4 Gk+4 
/~ ,  / \  /N  
Fig. 2. The "cascading" effect of uk 
on all stages after stage k. Arrows 
represent explicit effects defined by 
the recurrence relations (4)-(6). 
Effect of u K 
D 
Gk*s+Z 
x x I~  "x°+x 
GI 
i 
÷ex O+xG k 
x ,  • G . .  x ,  ,x  
G xO xe x Gk+2 llle Ox 
x • Ox i x e 
x 0 ! e++++e 
I I 
T O "Is T k Tk+ 2 Tk+. Tk+,.2 T ime 
u k l i t  during (T k, TN.I) 
Fig. 3. The ef fec t  of u , - -an approximation where a variation in u, only 
significantly influences glucose levels Gk + 2 to Gk +s + 2. 
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The partial derivatives, with respect o Uk, of the cost criterion are then set to zero, subject o 
the above approximation. Each equation 
OJ 
=0 (k = 0 to  N) ,  
t~u k
then only involves u k . . . . .  u k + ~ and could thus be used as an equation for u k + s in terms of quantities 
set or known at earlier times. This is what we need for closed-loop control. 
This method, then, gives a set of equations for uk (k = s . . . .  , N), leaving only u0 to us_ t to be 
found. In a situation where G is well above GB it may be optimal to set the insulin infusion rates 
u0 . . . .  , us_ ~ equal to Um~, especially if s is small. If this is not the case, some other means of finding 
the optimal control over stages 0 to s - 1 must be used (e.g. a grid search over all possible values 
of u). It will be seen that this approximate method involves a compromise between the number 
of initial stages for which the optimal Uk S are known and the number of steps ahead that Uk 
significantly affects. It does however give an algorithm in terms of the state variables (i.e. a 
closed-loop algorithm). 
We now derive the "optimal" glucose control algorithm subject to this approximation. If we 
consider, as discussed, that Uk first affects Gk + z and affects only s stages after, then 
OJ s+2 0 J  _ _  s+2 OGk+ ~ 
__  ~. ~, __  OGk +i= 26t ~, (Gk+ i -- GB) 
OUk i-- 20Gk+i OUk ~=2 OUk 
To extremize J we thus set the approximation 
s+2 OGk+ i 
(Gk+i- GB) = 0. (7) 
i=2 
Of the terms in the above equation, at stage k + s, Gk+~, Xk+~ and Ik+, are known and we wish 
to calculate the best infusion rate, Uk + s, for the next short time interval. Using equation (4) we can 
also find Gk+s+t from Gk+, and Xk+s. The "latest" glucose value, Gk+,+2, in equation (7) will be 
expressible in terms of Uk+~. We thus need to find expressions for OGk+i/OUk for i = 2 to s + 2. 
Proceeding to do this, OGk + ~/OUk (i = 2 to S + 1) may be found by differentiating appropriate forms 
of equations (4)-(6): 
OGk+i I _ (p l+Xk+,_t )OGk+i- I  OXk+'-I ] OGk+'-I 
OUk = OUk OUk Gk+i-1 6t + OU--------~ 
[from equation (4)]; with 
OXk+i - I  [Dt ,  i = 2, 
- - - - - - -~  OXk+i-2 Olk+i-2 i>2 ,  OUk ~02 ~ + 33 OU------'~' 
[From equation (5)]; and 
le t ,  i = 3, 
Olk+'-~=4 OIk_i_3 
OUk ~E2 ~kUk " i > 3, 
[from equation (6)]. With OG~+ ilOuk = 0 (since uk does not affect Gk+ 1), the above equations form 
a set of recurrence relations for OGk+i/aUk, i -- 2 to S + 1. 
Introducing Kj (i = 1 to 7) to simplify the algebra, we can thus calculate 
,+ l  ~Gk+i 
r ,  = . 
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Returning to equation (7) and using equation (4) again gives 
s+2 OGk+ i
0 = ,=2Z 
s+l 6~Gk+i OGk+s+ 2 
=,__2  + G,) 
-~-K[ dl-{[--(p, ~1-Xk+s+ i )Gk  +s+ l "Jff p4df  - Ginf]6t "~ Gk +s+ 1 - -GB} 
× :a,+.+,   x-ZSS+.+I / 
after applying the chain rule to OGk+,+2/OUk. 
In the above, the following are now known at time Tk+,: 
OGk+,+l 
K2 = - - ,  (from OGk+~/OUk, i = 2 . . . . .  S + 1, above), 
Ouk 
_ _  _ _  OXk+,+l 
OGk +, + 2 OXk +~ + j = _ Gk +~ + I - -  6t [using equation (4)], 
O X,  + , + I OUK OU, 
K3 -- 
and 
We thus obtain 
K4 = ( -P l  Gk+s+ j +P4 + Ginf)~t "+" Gk+s+l -- Gs. 
1(1 + (K4 - Xk +~+ tGk +s+ ,bt)[K3 + K2(1 - Xk +~+ ,bt)] = O. 
Referring to equations (4)-(6) and setting 
1(5 = Xk + ~D2 + Ik + sD3 -t- D4 
K6 = K,  - Gk +~+ l gs(~t 
and 
K7 = K2(l -- K56t) + K3, 
equation (8) becomes 
(so Xk+s+l = uk+,DI + Ks), 
(8) 
/(1 h- (K  6 - -  Uk +sDi Gk +s + 16t )(K7 -- uk +sDiK26t ) = O. 
This gives the quadratic in Uk + s: 
u~ +,D~ Jt2Gk +,+ . K2 - Uk +,D, 6t(K7Gk +,+ , + K2K6) + K, + K6K7 = 0. (9) 
It has been shown that everything in this equation except Uk +, is known at time Tk+,. 
One solution of equation (9) is spurious. Experience computing this function shows that one root 
remains roughly constant while the other solution varies to give values of Uk +s- (The "constant" 
solution may actually maximize  the cost.) 
The approximate solution to the optimization problem (which is in feedback form and, in fact, 
dependent upon the past history and not just the current state) is now to set uk+, equal to the 
solution of equation (9) when it falls within the bounds of the domain of u. Otherwise set Uk +, equal 
tO the value of Umi, or u,,ax that is closest o the solution. 
4. RESULTS AND DISCUSSION 
The results of applying this algorithm to Bergman's model are shown in Figs 4a-f. The examples 
given are representative, using tit = 10 min, N = 2160 rain (36 h) and s = 1. If s is set too large the 
roots of equation (9) may become complex, indicating that there is no value of the control that 
extremizes J. Setting 5t too small also results in instabilities. 
10-o 
_, 8.0 
o 6.0 
E 
E 4.0 
t9 
n 2.0 
0 
0 
I 
500 
I 
1000 
Closed-loop insulin infusion algorithms 
10.0 
8.0 
6.0 
4.0 
2.0 ! 
I I 0 ~ I 
1500 2000 0 500 
1 I I 
1000 1500 2000 
213 
20,0 
10.0 
E 
0-0 
-10.0 
i 
`500 
2% 
lO.O ~11~ 
I I I , o .o ,  w '  I I I I 
1000 1500 2000 [ _1  `500 1000 1500 2000 
-10.0 
x : :  
2.5 
2.0 
1.5 
1.0 
0.5 
0 
0 
I 
500 
I 
1000 
Time (min) 
I I 
1.5oo 2000 
Fig. 4(a). Effect of algorithm (9), parameter set 1, cost J, 
without glucose infusion. 
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Fig. 4(b). Effect of algorithm (9), parameter set 1, cost J, 
with glucose infusion. 
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Fig. 4(c). Effect of algorithm (9), parameter set 2, cost J, Fig. 4(d). Effect of algorithm (9), parameter set 2, cost J, 
without glucose infusion, with glucose infusion. 
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Fig. 4(f). Effect of algorithm (9), parameter set 3, cost J, 
with glucose infusion. 
In all cases (except parameter set 2 in the presence of a glucose infusion) control is effected via 
a clipped, damped sinusoidal plasma glucose profile. This compares well (qualitatively) with the 
results of Swan [l] where optimal control theory is applied to Ackerman's linear model of 
glucose/hormone kinetics. 
The algorithm automatically approaches the correct steady-state insulin infusion rate in both of 
the glucose infusion cases, except for parameter set 2 with the glucose infusion. The reason for this 
anomaly is simply that the maximum insulin infusion rate allowable is not high enough to cope 
with the added pressure of the glucose infusion in the insulin resistant case. Apart from this, control 
is theoretically good in all cases, with the glucose resistant subject appearing to be the hardest to 
bring back to basal glucose levels. 
The insulin profiles are not physiological (although also not outrageously bizzarre). This could 
be an effect of the very specific basal glucose level. An area of further research is to consider a 
target set for glucose levels rather than a specific basal value. 
An important consideration is the extent to which the model parameters appropriate to an 
individual patient may be estimated. Alternatively, can a patient be accurately categorized as 
having one of the representative parameter sets used in this study? Other areas of research include 
the case of a patient with some insulin production and the effect of using different cost criteria. 
The algorithm itself is in a closed-loop form, which may be clinically useful if the above questions 
can be answered satisfactorily. For close control, at least initially, a 10-min interval is not 
unreasonably short for glucose analysis [cf. 10]. The algorithm has been programmed on a personal 
computer and could thus be used in a computer-assisted insulin infusion system. 
5. CONCLUSIONS 
The non-linearity of models often encountered in biological contexts together with the preference 
for closed-loop control algorithms often render optimal control theory ineffective in the life 
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sciences. The method of  "discrete segments" can be an effective alternative to the usual methods 
of  optimal control theory. 
In the present study an optimal, " instantaneously" variable, insulin infusion rate algorithm for 
a patient otally dependent upon exogenous insulin has been derived which may be clinically useful. 
Metabolic control is theoretically good in all cases. It is hoped that, with the advent of  implantable 
glucose sensors and improved insulin delivery systems, glucose control in diabetic subjects will be 
greatly improved. 
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